OTLK Outlook Therapeutics, Inc.
Healthcare$0.31-6.94%ClosedMarket Cap: $12.7M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$1.00
Target (Median)
$1.00
Target Range
$1.00 - $1.00
Upside from current price: 222.7%
Rating Distribution
0 Strong Buy2 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | BTIG | downgrade | Neutral | Buy |
| 2026-03-11 | Ascendiant Capital | maintain | Buy | Buy |
| 2026-02-18 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| 2026-02-18 | Chardan Capital | maintain | Neutral | Neutral |
| 2026-01-05 | Chardan Capital | maintain | Neutral | Neutral |
| 2026-01-02 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| 2025-12-22 | Ascendiant Capital | maintain | Buy | Buy |
| 2025-09-30 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| 2025-09-22 | Ascendiant Capital | maintain | Buy | Buy |
| 2025-08-29 | HC Wainwright & Co. | downgrade | Neutral | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Sep 30 | $-0.27 | $64.0M | 2 |
| Sat Sep 30 | $-0.15 | $22.8M | 1 |
| Sun Sep 30 | $-0.12 | $29.7M | 1 |
| Mon Sep 30 | $-0.13 | $30.3M | 1 |